Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-24 @ 3:01 PM
NCT ID:
NCT00376259
Eligibility Criteria:
Inclusion Criteria:
* Documented compensated chronic hepatitis B defined by a clinical history compatible with chronic hepatitis B.
* Previous or current lamivudine treatment
* HBV DNA \> 6 log10 copies/mL
* Evidence of viral breakthrough
Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
* Patient is pregnant or breastfeeding.
* Patient is co-infected with hepatitis C virus (HCV), hepatitis D virus (HDV), or HIV.
* Patient has received any anti-HBV treatment for HBV infection other than lamivudine in the 12 months before Screening for this study.
Other protocol-defined exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00376259
Study Brief:
Protocol Section:
NCT00376259